Private Placement

Orosur Mining (TSX:OMI/AIM:OMI) announced a C$20 million private placement expected to close on October 2, 2025. The offering includes up to 58,823,530 new common shares. Additionally, 260,000 common shares were issued following consultant option exercises, and 8,675,418 shares were issued from warrant exercises, raising US$701,894. Post-these issuances, Orosur will have 325,758,894 common shares in issue, with 4,701,668 options and 22,834,404 warrants outstanding.

EnviroGold Global (ESGLF) announced a private placement aiming to raise up to C$5 million at C$0.09 per unit, with each unit including a share and a warrant to purchase another share at C$0.13. Funds will support technology development, demonstration plant operations for their NVRO Process™, debt reduction, and working capital. The offering is expected to close by October 15, 2025, pending regulatory approval. Some EnviroGold directors and officers may participate, relying on specific exemptions.

LQWD Technologies announced a non-brokered private placement to raise up to C$2 million by issuing units at C$1.50 each. Each unit includes one share and a warrant exercisable at C$2.00. Proceeds will fund Bitcoin purchases for deployment on the Lightning Network to generate yield. The placement includes participation from shareholders, directors, and management, subject to TSXV approval. Shares and warrants are subject to a four-month hold period, with a potential acceleration clause if the stock price increases.

Silver X Mining (AGXPF) increased its bought deal private placement from C$10 million to C$13 million due to strong investor demand. The offering consists of 26 million units at C$0.50 each, including a common share and a half warrant. Proceeds will fund exploration and capital expenditures at the Nueva Recuperada Silver District in Peru. Underwriters, led by Red Cloud Securities, have an option to purchase additional units to raise another C$3 million. The offering is expected to close on September 29, 2025.

Revive Therapeutics (RVVTF) is extending its private placement to raise up to $650,000 by issuing units at $0.021 each. Each unit includes a share and a warrant exercisable at $0.05 for 36 months. Having already raised $60,900 in the first tranche, the remaining $589,000 will be used for working capital and settling trade payables. The securities are subject to a four-month and one-day hold period. While providing needed capital, the offering involves significant dilution potential for shareholders.

Kronos Worldwide (KRO) is issuing €75M in additional 9.50% Senior Secured Notes due 2029 through its subsidiary, Kronos International, Inc. This increases the outstanding amount of these notes to €426.174M. Proceeds will primarily address maturing 3.75% Senior Secured Notes due September 2025, or repay amounts drawn from the Wells Fargo credit facility for the same purpose. The offering’s completion is subject to market conditions. The notes are guaranteed and secured by company assets.

Silver One Resources (SLVRF) increased its private placement to $6,016,600 due to oversubscription, offering 21,487,857 units at $0.28 each, comprising one common share and a half-warrant. Warrants allow purchase of a share at $0.40 within three years. Proceeds will fund exploration/drilling and working capital. The offering is subject to TSX Venture Exchange approval and a four-month resale restriction. Silver One focuses on silver project development, including the Candelaria Mine in Nevada.

Defence Therapeutics (DTCFF) announced a non-brokered private placement to raise up to $1.2 million by offering debenture units priced at $1,000 each. Each unit includes an 8% convertible debenture (convertible at $0.60 per share) maturing in two years and 1,666 common share purchase warrants (exercisable at $0.75 per share for two years). Interest will be paid annually in cash or shares at the company’s discretion. Securities are subject to a four-month hold. The offering aims to fund the company’s antibody-drug conjugate (ADC) programs.

Discovery Energy Metals (DEMCF) closed a $1 million non-brokered private placement, issuing 10 million units at $0.10 each, comprising one common share and a transferable warrant. Warrants are exercisable at $0.15 per share for 24 months. Proceeds will fund working capital and property exploration. Issued securities are subject to a four-month statutory hold. The placement creates immediate shareholder dilution, with potential for further dilution upon warrant exercise.

Cambricon, a Chinese AI chip company, has received approval from the Shanghai Stock Exchange for a RMB 4 billion private placement. The funds will be used for AI chip and software platform development, particularly for large-scale AI models, and to supplement working capital. Cambricon’s Q1 2025 revenue surged by 4230.22% year-on-year, with net profit also significantly increasing. The company focuses on cloud, edge products, and IP licensing, aiming to build a comprehensive AI ecosystem.